Low-T drug alleged to have caused 56-year-old’s stroke
On Feb. 26, 2014, a man who took Testim testosterone gel filed a federal lawsuit against Auxilium Pharmaceuticals, the maker of the low-T drug. Testim is marketed as a safe and effective medical treatment used for testosterone replacement therapy. The Cochran Firm, D.C. did not file this testosterone lawsuit but our team of experienced attorneys are actively reviewing claims by men who used testosterone drugs and suffered adverse health consequences.
The lawsuit filed in U.S. District Court for the Central District of California says Auxilium of engaging in an aggressive physician and consumer-targeting advertising campaign through TV, radio, magazine, and online ads. The complaint also states that Auxilium funded unbranded “disease awareness” campaigns designed to make men think they suffered from “low T.”
The plaintiff – 56-year-old Joseph Myers of Fullerton, California – was prescribed Testim testosterone gel for symptoms he believed were related to low testosterone after seeing Testim advertisements. Myers suffered a stroke after using Testim, which negatively impacted his personal and professional life. According to his lawsuit, Myers suffered memory loss and now needs oxygen therapy. Prior to using Testim, Myers says he had no history of strokes, blood clots, or other heart issues.
The Testim testosterone gel lawsuit accuses Auxilium of failing to warn the public about the health risks that may be associated with the low-T gel. The federal complaint additionally accuses Auxilium of negligence and fraud. The lawsuit seeks, among other things, punitive damages and compensation for lost earnings and medical expenses. Read the Testim testosterone gel lawsuit to learn more detail about low-T litigation.